You are viewing the site in preview mode
Skip to main content
|
Group
|
Weight measurement
|
|---|
|
Liver weight(g)
|
Liver weight/body weight (g/g)
|
Body mass index (kg/m2)
|
Body Weight Gain(g)
|
|---|
|
NC
|
6.24 ± 0.53
|
0.025 ± 0.002
|
5.66 ± 0.18
|
71.67 ± 27.05
|
|
FC
|
6.98 ± 0.24*
|
0.029 ± 0.003
|
5.70 ± 0.39
|
79.67 ± 19.36
|
|
SC
|
6.34 ± 0.41
|
0.026 ± 0.002
|
5.65 ± 0.19
|
71.83 ± 9.15
|
|
FTH
|
6.71 ± 0.33
|
0.027 ± 0.003
|
5.81 ± 0.48
|
74.33 ± 17.67
|
|
FFH
|
6.50 ± 0.36
|
0.026 ± 0.004
|
5.75 ± 0.28
|
72.67 ± 25.90
|
- At the end of the trial liver weight, liver weight/body weight ratio, body mass index and body weight gain were measured and calculated. NC normal control, FC fructose control, SC silymarin control, FTH fructose + 200 mg/kg silymarin, FFH fructose + 400 mg/kg silymarin. Data were presented as mean ± SD. N = 6 for each group. * p < 0.05 vs. NC
